If you’ve ever been offered genetic carrier screening, whether inside or outside a Jewish context, chances are cystic fibrosis (CF) was at the top of the list.
What is CF?
CF is a genetic condition that affects the lungs and digestive system. Thick mucus builds up, making it harder to breathe and increasing the risk of lung infections. With modern treatments, people with CF are living longer than ever — many into their 40s and beyond — but it remains a serious, life-shortening condition.
Why is it always screened?
-
Common across populations: About 1 in 25 Caucasians is a carrier, but carriers are found in every ethnic group.
-
Life-changing impact: Early diagnosis allows for interventions that improve quality and length of life.
-
Universal guidelines: Professional groups like ACOG and ACMG recommend offering CF screening to allindividuals considering pregnancy.
The inheritance pattern:
-
If both partners are carriers, each pregnancy has a 25% chance of CF.
-
If only one partner is a carrier, the child cannot have CF — but could still be a carrier.
Treatment advances:
Over the last decade, new drugs called “CFTR modulators” have transformed CF care. They don’t just treat symptoms — they target the underlying protein defect.
Takeaway: Cystic fibrosis became the model for universal screening because it’s common, serious, and better managed when we know in advance.